Guide to DI (Exam 1) Flashcards

1
Q

Drug Information

A

Facts or advice on drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug Information Center

A

A physical location where pharmacists have the resources to provide drug information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug Information Service

A

A professional service providing drug information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Optimal drug development requires a balance between achieving ________ and eliciting desired ______.

A

therapeutic concentrations (PK)

therapeutic effects (PD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetics (PK)

A

Body on drug
ADME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacodynamics (PD)

A

Drug on body
Drug-receptor interactions
MOA
Dose-response relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drug Development Stages

A

Pre-clinical
Phase 1
Phase 2
Phase 3
FDA approval
Phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pre-clinical testing

A

In vitro/vivo studying on cells and animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phase 1

A

Safety and tolerability of drug in 20-100 healthy humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phase 2

A

Effect of drug in 100-200 patients with target disease
Efficacy and dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What percent of drugs will enter phase 3?

A

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phase 3

A

Effect of drug in a few thousand patients with target disease
Double-blind design

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Applying for FDA Approval

A

NDA reviewed by FDA and approved/denied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phase 4

A

Post-marketing monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MedWatch

A

Collects reports about unexpected side effects, quality issues, medication errors, and therapeutic failures
Voluntary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FAERS

A

FDA Adverse Event Reporting System
Information on drug and biologic reports

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

VAERS

A

CDC Vaccine Adverse Event Reporting System

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Prescribing Information (PI)

A

Package insert, prescribing information, prescription drug labeling, product label
NO “off-label” indications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which phase of FDA drug development is most concerned with human pharmacodynamic parameters of the drug?

A

Phase 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the primary objective of Phase 4 clinical trials in FDA drug development?

A

Gather additional safety data in real-world setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Black Box Warning (BBW)

A

Contraindications
Warnings and Precautions
Adverse Reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Drugs with serious safety concerns may require enrollment in _____ to manage.

A

Risk Evaluation and Mitigation Strategies (REMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Risk Evaluation and Mitigation Strategies (REMS)

A

FDA required safety programs for meds with specific serious adverse effects
Ex. Clozapine REMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Adverse Drug Event

A

Harm caused by appropriate OR inappropriate use of drug
includes adverse drug reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Adverse Drug Effect
potentially harmful effect due to use of drug discovered during clinical exam or lab value
26
Adverse Drug Reaction
Harm directly caused by drug under appropriate use and normal conditions
27
Common Terminology Criteria for Adverse Events (CTCAE)
System used for reporting and grading severity of adverse events Grade 1-5
28
Grade 1 Mild
Asymptomatic or mild symptoms No intervention
29
Grade 2 Moderate
Minimal, local, noninvasive intervention Limits daily activities
30
Grade 3 Severe
Medically significant but not life threatening Hospitalization required
31
Grade 4 Life-threatening
Urgent intervention ICU
32
Grade 5
Death :o
33
Full Prescribing Information (PI)
Drug Interactions Drug Abuse and Dependence Overdosage References
34
Drug Interactions vs Drug Incompatibilities
Interactions - in body Incompatibility - in vitro
35
Electronic "Drug ID" Tool
Drug identification Enter letters and numbers from pill
36
Drug Instability
Eventual drug incompatibility or degradation
37
Where clinical trials can register to provide the public with transparent information?
ClinicalTrials.gov
38
Where to find PI?
DailyMed Product Website Manufacturer's Website Drugs@FDA OTC Monographs@FDA Paper label attachment NO GOOGLE
39
Types of DI Resources
Primary Secondary Tertiary
40
Tertiary Resource
Summaries of available info
41
Secondary Resource
Databases which link primary sources
42
Primary Resource
Present new/original material
43
Which resource is the best starting point for gathering information?
Tertiary
44
Drug Monograph
Structured document that reviews major features of a drug product Limited to FDA-approved info
45
Monograph vs monogram
idk just remember to look for the word monoGRAPH probs a true/false question edit: monogram is a t-shirt print with initials
46
Drug Monograph Body Contents
Indications (off-label as well) Guidelines Cost comparison
47
Drug Monograph Sources
PI, Package Insert, NDA, ANDA
48
Drug Compendia
sources for use in determining medically-accepted indication of drugs and biologicals used off-label in an anti-cancer chemo regimen
49
Types of Compendia
AHFS DI Micromedex Lexicomp Clinical Pharmacy NCCN Drugs and Biologics
50
AHFS DI
"Need to know" about drugs
51
Micromedex
Summary info Links to REDBOOK and Trissel's
52
Lexicomp/drug
Quick look up Links to AHFS DI, Briggs, and Trissel's
53
Clinical Pharmacology
"Find by" feature Links to AHFS DI, Harriet Lane, Trissel's
54
NCCN Drugs and Biologics
Decision-making for patients's w cancer
55
Which compendium provides access to Harriet Lane Handbook?
Clinical Pharmacology
55
Disease Oriented Resources for Therapeutics
Koda-Kimble and Young's Applied Therapeutics Pharmacotherapy (Dipiro)
56
Disease Oriented Resources for Symptoms and Diagnosis
Goldman's Harrison's
57
Disease Oriented Resources for General Background Websites
Pharmacist's Letter Dynamed / dynamedex UpToDate Epocrates Merck Manual Medscape
58
Disease Oriented Resources for Pharmacology
Brody's Basic & Clinical (Katzung) Goodman $ Gilman's
59
Specialty Resources for Compounding and IV Stability
King Guide Trissel's IJPC Compounding Today Remington US Pharmacopoeia
60
Specialty Resources for Drug Shortages
ASHP and FDA Drug shortages
61
Specialty Resources for OTC
Handbook of Nonprescription Drugs OTC Monographs@FDA
62
Specialty Resources for Drug Interactions
Stockley's Liverpool Hansten and Horn
63
Specialty Resources for ADRs
FAERS and VAERS MedWatch Meyler's Reactions Weekly Side effects of Drugs Annual
64
Specialty Resources for Toxicology
Posion Control Center PoisinDex Lexi-Tox ToxEd Goldfrank's Casarett & Doull's
65
Specialty Resources for Pharmaceutical Industry
Phact MI
66
Is IV compatibility the same as absence of drug interaction?
NO!
67
Number for poison control
1-800-222-1222
68
Specialty Resources for Veterinary
Merck Manual Plumb's
69
Specialty Resources for Pediatrics
Harriet Lane Neofax TeddyBear
70
Specialty Resources for Pharmacogenomics
Pharmacogenomics and Lab Tests CPIC PharmGKB RxPgx
71
Specialty Resources for Pregnancy/Lactation
Brigg's LactMed
72
Specialty Resources for Geriatrics
Beers Criteria
73
Specialty Resources for infectious Disease
Sanford Guide
74
Specialty Resources for Immunizations
CDC Immunization Schedule Immunization Action Coalition
75
Specialty Resources for Drug Information
Drug Information RxList.com
76
Specialty Resources for International
Martindale Index Nominum WHO European Med Agency
77
Specialty Resources for Herbal Therapies
Natural Medicines Database Examine.com NIH Office About Herbs
78
Specialty Resources for Enteral Administration
Handbook of Drug Administration via Enteral Feeding Tubes
79
Green Book
Animal Products
80
Orange Book
Therapeutic Equivalence
81
Purple Book
Biosimilars
82
Pink Book
Vaccine-Preventable Diseases
83
REDBOOK
Pricing Info
84
American Academy of Pediatrics Red Book
Pediatric Infectious Disease
85
Yellow Book
Travelers' Health Info
85
What do most health care professionals use to search information?
Specific medication website/apps
86
Systematic Approach to Answering DI Questions
1. Receive 2. Expand 3. Classify 4. Search 5. Evaluate 6. Formulate 7. Communicate 8. Follow-up
87
Why does complexity matter when searching databases?
Obvious search terms for low-mid complexity Specific search terms for mid-high complexity
88
Secondary resource strategies
Select appropriate search terms Determine what filters need to be placed
89
Assess primary literature by
Validity of journal Date published Target audience Author credentials
90
Formulating a response includes
Patient factors Disease factors Medication factors Background info Special circumstances
91
Analysis vs. Synthesis
Analysis: breaking down into component parts Synthesis: Process of combining varied and diverse ideas into a coherent whole
92
When providing a response
List all resources searched Provide facts Summarize
93
Which reference style do we use?
AMA style
94
AMA Style
Author(s),Title, Journal name Year;vol(issue No.):inclusive pages. DOI
95
Citing package insert
Medication name. Package insert. Publisher; Year. Accessed month, day, year. doi/url